Video Experimental Relacionado
Updated: Feb 6, 2026
08:15
Polymeric Microneedle Array Fabrication by Photolithography
Published on: November 17, 2015
13.0K
Array de Microagujas Dentadas Novedoso para la Administración Dual de Fármacos para Hemangiomas Infantiles Gruesos
Pei Wang1, Shih-Jen Chang1, Yajing Qiu1
1Department of Plastic and Reconstructive Surgery, Shanghai Key Laboratory of Tissue Engineering, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Advanced healthcare materials
|February 5, 2026
Resumen
Un nuevo sistema de microagujas administra fármacos duales para hemangiomas infantiles (HI). Esta terapia reduce eficazmente el volumen tumoral e inhibe el crecimiento de los HI, ofreciendo una opción de tratamiento mínimamente invasiva prometedora.
Área de la Ciencia:
- Ciencia de Biomateriales
- Dermatología
- Nanotecnología
Sus antecedentes:
- Los hemangiomas infantiles (HI) presentan complicaciones, especialmente lesiones gruesas que no responden al timolol tópico debido a una pobre penetración en la piel.
- El propranolol oral para los HI tiene limitaciones que incluyen efectos secundarios sistémicos y resistencia.
- Los tratamientos actuales para los HI requieren mejores métodos de administración de fármacos para lograr eficacia y seguridad.
Objetivo del estudio:
- Desarrollar un novedoso sistema de microagujas (MN) para la administración dual de fármacos específica en profundidad para tratar hemangiomas infantiles.
- Combinar bleomicina (BLM) para ablación profunda y timolol (TM) para vasoconstricción superficial en una terapia sinérgica (TM-BLM@MN).
- Evaluar la eficacia del sistema TM-BLM@MN in vitro e in vivo para el tratamiento de hemangiomas infantiles.
Principales métodos:
- Desarrollo de un sistema de microagujas (MN) dentadas para la administración dual de fármacos de bleomicina (BLM) y timolol (TM).
- Evaluación in vitro del TM-BLM@MN sobre la proliferación, migración y formación de tubos de las células madre del hemangioma.
- Evaluación in vivo de la eficacia del TM-BLM@MN en la reducción del volumen tumoral y la angiogénesis patológica del hemangioma infantil.
Principales resultados:
- El TM-BLM@MN demostró una inhibición significativa de la proliferación, migración y formación de tubos de las células madre del hemangioma in vitro.
- El tratamiento in vivo con TM-BLM@MN resultó en una reducción 1.93 veces mayor del volumen tumoral en comparación con los controles.
- El análisis histológico confirmó que el TM-BLM@MN suprimió marcadamente la angiogénesis patológica en los hemangiomas infantiles.
Conclusiones:
- El novedoso sistema de microagujas dentadas (TM-BLM@MN) proporciona una plataforma eficaz de administración dual de fármacos específica en profundidad para hemangiomas infantiles.
- Este enfoque mínimamente invasivo muestra una alta eficacia para el tratamiento de lesiones de HI gruesas.
- El sistema TM-BLM@MN tiene un potencial significativo para la traslación clínica y la facilitación de la terapia domiciliaria para los HI.
Videos de Conceptos Relacionados
01:16Drug Delivery: Overview
879
The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
879
01:18Drug Delivery: Enteral Route
1.8K
The enteral drug administration involves three primary routes: oral, sublingual, and buccal. Oral ingestion is the most prevalent, safe, economical, and convenient method for drug administration. However, it has certain drawbacks, including limited absorption due to the drug's low water solubility or poor membrane permeability, possible emesis from GI mucosa irritation, destruction of drugs by digestive enzymes or low gastric pH, and irregular absorption along with food or other drugs.
1.8K
01:29Drug Delivery: Parenteral Route
1.7K
The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
1.7K
01:22Drug Delivery: Miscellaneous Routes
832
Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection, and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
832
01:19Drug Absorption Mechanism: Carrier-Mediated Membrane Transport
6.2K
Certain large, lipid-insoluble drug molecules that resemble amino acids, peptides, or glucose, require specialized carrier proteins to facilitate their diffusion across cell membranes. This transport can occur through either facilitated diffusion, which does not require energy input, or active transport, which does require energy input.
Facilitated diffusion is a passive process that utilizes human Solute Carrier (SLC) transporters. These transporters bind to the drug, undergo structural...
Facilitated diffusion is a passive process that utilizes human Solute Carrier (SLC) transporters. These transporters bind to the drug, undergo structural...
6.2K
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
912
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
912